Ocular Therapeutix (OCUL) Other Operating Expenses (2013 - 2026)
Ocular Therapeutix's quarterly Other Operating Expenses came in at $17.9 million in Q1 2026, up 16.2% year-on-year from $15.4 million in Q1 2025, and up 23.06% quarter-over-quarter from $14.6 million in Q4 2025.
Ocular Therapeutix has reported Other Operating Expenses for 14 years, with the latest figure at $17.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses rose 16.2% year-over-year to $17.9 million; the trailing twelve-month figure through Mar 2026 stood at $63.0 million (up 23.23% YoY), and the FY2025 full-year result was $60.5 million, up 28.13% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $17.9 million, up from $14.6 million in the prior quarter.
- The five-year high for Other Operating Expenses was $17.9 million in Q1 2026, with the low at $10.4 million in Q1 2022.
- Average Other Operating Expenses over 5 years is $12.7 million, with a median of $12.0 million recorded in 2023.
- Year-over-year, Other Operating Expenses declined 7.91% in 2023 and jumped 36.25% in 2025.
- Tracing OCUL's Other Operating Expenses over 5 years: stood at $11.5 million in 2022, then declined by 7.91% to $10.6 million in 2023, then climbed by 13.54% to $12.1 million in 2024, then increased by 20.56% to $14.6 million in 2025, then grew by 23.06% to $17.9 million in 2026.
- The last three Other Operating Expenses figures came in at $17.9 million (Q1 2026), $14.6 million (Q4 2025), and $14.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.91 Mn |
| Dec 31, 2025 | 14.55 Mn |
| Sep 30, 2025 | 14.86 Mn |
| Jun 30, 2025 | 15.67 Mn |
| Mar 31, 2025 | 15.41 Mn |
| Dec 31, 2024 | 12.07 Mn |
| Sep 30, 2024 | 12.13 Mn |
| Jun 30, 2024 | 11.50 Mn |
| Mar 31, 2024 | 11.51 Mn |
| Dec 31, 2023 | 10.63 Mn |
| Sep 30, 2023 | 10.69 Mn |
| Jun 30, 2023 | 12.46 Mn |
| Mar 31, 2023 | 12.05 Mn |
| Dec 31, 2022 | 11.54 Mn |
| Sep 30, 2022 | 11.26 Mn |
| Jun 30, 2022 | 11.30 Mn |
| Mar 31, 2022 | 10.36 Mn |
| Dec 31, 2021 | 10.24 Mn |
| Sep 30, 2021 | 10.89 Mn |
| Jun 30, 2021 | 9.49 Mn |
| Mar 31, 2021 | 8.98 Mn |
| Dec 31, 2020 | 7.49 Mn |
| Sep 30, 2020 | 6.97 Mn |
| Jun 30, 2020 | 6.29 Mn |
| Mar 31, 2020 | 7.95 Mn |
| Dec 31, 2019 | 7.98 Mn |
| Sep 30, 2019 | 7.58 Mn |
| Jun 30, 2019 | 7.78 Mn |
| Mar 31, 2019 | 3.48 Mn |
| Dec 31, 2018 | 2.41 Mn |
| Sep 30, 2018 | 1.18 Mn |
| Jun 30, 2018 | 1.02 Mn |
| Mar 31, 2018 | 797,000.00 |
| Dec 31, 2017 | 1.02 Mn |
| Sep 30, 2017 | 3.36 Mn |
| Jun 30, 2017 | 6.94 Mn |
| Mar 31, 2017 | 6.14 Mn |
| Dec 31, 2016 | 2.65 Mn |
| Sep 30, 2016 | 1.41 Mn |
| Jun 30, 2016 | 1.60 Mn |
| Mar 31, 2016 | 1.49 Mn |
| Dec 31, 2015 | 1.24 Mn |
| Sep 30, 2015 | 889,000.00 |
| Jun 30, 2015 | 1.12 Mn |
| Mar 31, 2015 | 926,000.00 |
| Dec 31, 2014 | 688,000.00 |
| Sep 30, 2014 | 511,000.00 |
| Jun 30, 2014 | 555,000.00 |
| Mar 31, 2014 | 319,000.00 |
| Dec 31, 2013 | 197,000.00 |
| Sep 30, 2013 | 148,000.00 |
| Jun 30, 2013 | 143,000.00 |